BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 9222654)

  • 1. Ocular vascular endothelial growth factor levels in diabetic rats are elevated before observable retinal proliferative changes.
    Sone H; Kawakami Y; Okuda Y; Sekine Y; Honmura S; Matsuo K; Segawa T; Suzuki H; Yamashita K
    Diabetologia; 1997 Jun; 40(6):726-30. PubMed ID: 9222654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor and its receptors in control and diabetic rat eyes.
    Gilbert RE; Vranes D; Berka JL; Kelly DJ; Cox A; Wu LL; Stacker SA; Cooper ME
    Lab Invest; 1998 Aug; 78(8):1017-27. PubMed ID: 9714188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy.
    Amin RH; Frank RN; Kennedy A; Eliott D; Puklin JE; Abrams GW
    Invest Ophthalmol Vis Sci; 1997 Jan; 38(1):36-47. PubMed ID: 9008628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas.
    Murata T; Nakagawa K; Khalil A; Ishibashi T; Inomata H; Sueishi K
    Lab Invest; 1996 Apr; 74(4):819-25. PubMed ID: 8606491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High levels of pigment epithelium-derived factor in the retina of a rat model of type 2 diabetes.
    Matsuoka M; Ogata N; Minamino K; Higuchi A; Matsumura M
    Exp Eye Res; 2006 Jan; 82(1):172-8. PubMed ID: 16054135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease.
    Vinores SA; Youssri AI; Luna JD; Chen YS; Bhargave S; Vinores MA; Schoenfeld CL; Peng B; Chan CC; LaRochelle W; Green WR; Campochiaro PA
    Histol Histopathol; 1997 Jan; 12(1):99-109. PubMed ID: 9046048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased levels of vascular endothelial growth factor and advanced glycation end products in aqueous humor of patients with diabetic retinopathy.
    Endo M; Yanagisawa K; Tsuchida K; Okamoto T; Matsushita T; Higuchi M; Matsuda A; Takeuchi M; Makita Z; Koike T
    Horm Metab Res; 2001 May; 33(5):317-22. PubMed ID: 11440280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of vascular endothelial growth factor (VEGF) and its receptors is regulated in eyes with intra-ocular tumours.
    Stitt AW; Simpson DA; Boocock C; Gardiner TA; Murphy GM; Archer DB
    J Pathol; 1998 Nov; 186(3):306-12. PubMed ID: 10211121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-induced vascular endothelial growth factor expression in retina.
    Lu M; Amano S; Miyamoto K; Garland R; Keough K; Qin W; Adamis AP
    Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3281-6. PubMed ID: 10586954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The temporal and spatial vascular endothelial growth factor expression in retinal vasculogenesis of rat neonates.
    Murata T; Nakagawa K; Khalil A; Ishibashi T; Inomata H; Sueishi K
    Lab Invest; 1996 Jan; 74(1):68-77. PubMed ID: 8569199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of retinal microcirculatory alterations in the Goto-Kakizaki rat. A spontaneous model of non-insulin-dependent diabetes.
    Miyamoto K; Ogura Y; Nishiwaki H; Matsuda N; Honda Y; Kato S; Ishida H; Seino Y
    Invest Ophthalmol Vis Sci; 1996 Apr; 37(5):898-905. PubMed ID: 8603874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy.
    Hogeboom van Buggenum IM; Polak BC; Reichert-Thoen JW; de Vries-Knoppert WA; van Hinsbergh VW; Tangelder GJ
    Diabetologia; 2002 Feb; 45(2):203-9. PubMed ID: 11935151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constitutive expression of VEGF, VEGFR-1, and VEGFR-2 in normal eyes.
    Kim I; Ryan AM; Rohan R; Amano S; Agular S; Miller JW; Adamis AP
    Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2115-21. PubMed ID: 10440268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor- and platelet-derived growth factor-angiogenesis depressed but fetal bovine serum-angiogenesis enhanced choroidal tissue cultures of streptozotocin-diabetic Wistar and GK rats.
    Kimura I; Yanagita S; Kobayshi S; Fukuta M; Okabe M
    Int Angiol; 2000 Mar; 19(1):26-34. PubMed ID: 10853682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of vascular endothelial growth factor (VEGF) does not affect early renal changes in a rat model of lean type 2 diabetes.
    Schrijvers BF; De Vriese AS; Tilton RG; Van de Voorde J; Denner L; Lameire NH; Flyvbjerg A
    Horm Metab Res; 2005 Jan; 37(1):21-5. PubMed ID: 15702434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical factors related to the aqueous levels of vascular endothelial growth factor and hepatocyte growth factor in proliferative diabetic retinopathy.
    Shinoda K; Ishida S; Kawashima S; Wakabayashi T; Uchita M; Matsuzaki T; Takayama M; Shinmura K; Yamada M
    Curr Eye Res; 2000 Aug; 21(2):655-61. PubMed ID: 11148602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes-Induced Inflammation and Vascular Alterations in the Goto-Kakizaki Rat Retina.
    Hachana S; Pouliot M; Couture R; Vaucher E
    Curr Eye Res; 2020 Aug; 45(8):965-974. PubMed ID: 31902231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor and vascular permeability changes in human diabetic retinopathy.
    Mathews MK; Merges C; McLeod DS; Lutty GA
    Invest Ophthalmol Vis Sci; 1997 Dec; 38(13):2729-41. PubMed ID: 9418725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.
    Aiello LP; Avery RL; Arrigg PG; Keyt BA; Jampel HD; Shah ST; Pasquale LR; Thieme H; Iwamoto MA; Park JE
    N Engl J Med; 1994 Dec; 331(22):1480-7. PubMed ID: 7526212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy.
    Watanabe D; Suzuma K; Matsui S; Kurimoto M; Kiryu J; Kita M; Suzuma I; Ohashi H; Ojima T; Murakami T; Kobayashi T; Masuda S; Nagao M; Yoshimura N; Takagi H
    N Engl J Med; 2005 Aug; 353(8):782-92. PubMed ID: 16120858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.